Utilization of Chinese medicine for respiratory discomforts by patients with a medical history of tuberculosis in Taiwan

Abstract

BackgroundTuberculosis (TB) is one of the world’s major communicable infectious diseases, and it still imposes a great health burden in developing countries. The development of drug-resistant TB during the treatment increases the treatment complexity, and the long-term pulmonary complications after completing treatment raise the epidemic health burden. This study intended to investigate the utilization of Chinese medicine (CM) for respiratory symptoms by patients with a medical history of TB in Taiwan.MethodsWe analyzed a cohort of one million individuals who were randomly selected from the National Health Insurance Research Database in Taiwan. The inclusion criteria of patients (n = 7905) with history of TB (ICD-9-CM codes 010–018 and A02) were: (1) TB diagnosed between January 1, 1997 and December 31, 2010 (2) 18 years old or over (3) Clinical records for at least 2 months with complete demographic information (4) Record of treatment with first-line TB medication prescriptions. CM users for conditions other than respiratory discomforts (n = 3980) were excluded. Finally, a total of 3925 TB patients were categorized as: CM users for respiratory discomforts (n = 2051) and non-CM users (n = 1874).ResultsAmong the 3925 subjects, 2051 (52.25%) were CM users, and 1874 (44.753%) were non-CM users. Female patients and those who were younger (18–39 y/o) and who lived in urbanized areas relatively tended to be CM users (p < .0001). Most of the CM users (1944, 94.78%) received Chinese medicines. The most commonly prescribed herbal formulas and single herbs were Xiao-Qing-Long-Tang and Radix Platycodonis (Jie-Geng), respectively. The core pattern of Chinese medicines for TB patients consisted of Ma-Xing-Gan-Shi-Tang, Bulbus Fritillariae Thunbergii (Bei-Mu), Radix Platycodonis (Jie-Geng) and Semen Armeniacae (Xing-Ren).ConclusionsThe use of CM is popular among patients with a medical history of TB complicated with long-term respiratory discomforts in Taiwan. Further pharmacological investigations and clinical trials are required.

Lost to Follow-Up among Tuberculosis Patients during the Public-Private Mix Era in Rural Area of Indonesia

“…These findings suggest that patients tend to use complementary medicine. Previous research has shown that in general, Asians use complementary medicine in addition to conventional medicine ( 23 ). In addition, community's influence plays a strong role in TB medication in Asia.…”

Integrated therapeutic plasma exchange and traditional Chinese medicine treatment in a patient with severe COVID-19: A case report

“…The Ma-Xing-Shi-Gan-Tang, consisting of Ephedra , semen Pruni armeniacae , licorice and gypsum , is generally used to treat lung heat. Previous studies on Ma-Xing-Shi-Gan-Tang focus on treating chronic obstructive pulmonary disease, allergic rhinitis and tuberculosis [14] , [15] , [16] . Ma-Xing-Shi-Gan-Tang has been reported to have antitussive and antipyretic effects, which may be due to the inhibition of histaminergic and acetylcholinergic receptors that activate both sympathomimetic α- and β-adrenergic receptors [17] .…”

The Chang Gung Research Database: Multi‐institutional real‐world data source for traditional Chinese medicine in Taiwan

“…Although Western medicine is the mainstream in Taiwan, about 30% of patients have used TCM to treat problems and diseases of the major human organ systems recognized by Western medicine 17 . Several studies have reported on TCM uses among patients with different diseases, based on analysis of the NHIRD 18‐21 …”